Wells Fargo & Company Care Dx, Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CDNA
# of Institutions
169Shares Held
48.7MCall Options Held
60.8KPut Options Held
34.9K-
Black Rock Inc. New York, NY5.29MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$104 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$92.5 Million1.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$70.7 Million0.89% of portfolio
-
Gagnon Securities LLC2.17MShares$51.4 Million7.99% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.26B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...